vimseltinib 30 MG Oral Capsule [Romvimza]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

vimseltinib 30 MG Oral Capsule [Romvimza]

30 MG · Oral Capsule · oral

A form of vimseltinib →

vimseltinib 30 MG Oral Capsule [Romvimza] — Other protein kinase inhibitors. Strength, form, class, interactions & more.

vimseltinib 30 MG Oral Capsule [Romvimza]

Active ingredient

Classification

Other protein kinase inhibitors

Drug interactions

Vimseltinib may increase the exposure of certain drug substrates when used concomitantly.

  • majorP-glycoprotein (P-gp) substrates — Increased exposure of P-gp substrates
  • majorBreast Cancer Resistance Protein (BCRP) substrates — Increased exposure of BCRP substrates
  • majorOrganic Cation Transporter 2 (OCT2) substrates — Increased exposure of OCT2 substrates

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.